MIAMI - TelAve -- RevGenetics is disrupting the metabolic support market today with the commercial launch of DiBerberine 300x, an advanced enteric-coated dihydroberberine (DHB) supplement. By directly addressing the industry-wide "berberine absorption gap," RevGenetics exposes a flaw found in nearly every major competing brand: the failure to protect the active compound from stomach acid degradation and P-glycoprotein (P-gp) efflux pumps.

"The question we kept asking was: why is the supplement industry selling a mechanism - AMPK activation - with a delivery system that undermines the mechanism?" said RevGenetics founder Anthony Loera. "Most every major brand in the berberine category is selling a standard vegetarian capsule with berberine. Nobody in the supplement industry was solving them in a single product."

More on TelAve News

• Jackets for Jobs Hosts Smart & Sexy® Day Detroit for Women's History Month
• Tint Academy Training in Dallas Texas: Learn Window Tint & PPF Installation
• ASTPP Launches Advanced Telecom Billing Software to Simplify Billing for VoIP Providers
• $IBG accelerates toward transformative merger with BlockFuel as $6 million raise fuels dual-industry growth strategy: N A S D A Q: IBG
• High-Growth Power Infrastructure Play Targets AI Boom: 1606 Corp. Executes Aggressive Texas Expansion Strategy: 1606 Corp. (Stock Symbol: CBDW) $CBDW

Unlike standard formulas, The DiBerberine 300x Triple-Action Protocol sets a new standard by combining:

• Enteric Capsule Technology: Borrowing from pharmaceutical methods, this acid-resistant capsule bypasses the stomach without dissolving, preventing DHB from reverting to standard berberine HCl and ensuring release in the small intestine.
• DiBerberine™ Proprietary Blend (500mg per capsule): This leverages the profound pharmacokinetic advantage of DHB. A 2022 study showed a 100mg dose yielded ~6.7x greater plasma exposure than 500mg of standard berberine HCl.
• RGBooster1™: A patent-pending (U.S. App. No. 63/837,080) flavonoid complex. Internal assays demonstrate our Sophora japonica extract is up to 300x more potent than piperine at modulating the P-gp active transport mechanism that expels compounds from intestinal cells.

"Enteric coating isn't new technology," Loera stated. "Applying that technology to DHB was the obvious move. It just hadn't been done in a commercially available formula."

More on TelAve News

• Accelerating the Transformation into a U.S. Nuclear Fuel Cycle Leader: Frontier Nuclear and Minerals Inc. (N A S D A Q: FNUC)
• Ozz Metals Ltd Secures 1-Tonne Gold Offtake Agreement
• Jet Set: The Ultimate Coachella Afterparty
• Heritage at Manalapan Introduces New Single-Family Home Community in One of Monmouth County's Most Desirable Locations
• Compliant Workspace announces partnership with Blackpoint Cyber

Manufactured in the USA in a cGMP-certified, third-party tested facility, DiBerberine 300x is now available at revgenetics.com. A 30-day supply (30 enteric capsules) is priced at $44.95.

Health and wellness influencers, practitioners, and marketers interested in partnering with RevGenetics for this launch can access the affiliate program at getlink.revgenetics.com.